AI tool helps find life-saving medicine for rare disease
Detailed in a new paper published in NEJM, a group led by researchers at the Perelman School of Medicine at the University of Pennsylvania used an AI technique called machine learning to determine that adalimumab -- a monoclonal antibody which is FDA-approved to treat conditions ranging from arthritis to Crohn's disease -- was the "top-predicted" new treatment that was likely to work for iMCD.
